# Avail Medsystems has moved to Mendaera

> Avail Medsystems built a subscription telepresence system that let surgeons and medical device experts collaborate live from outside the operating room. After Avail shut down in 2023 when it could not secure new funding, Mendaera bought substantially all of its assets in 2024 and continued supporting existing console customers. Mendaera's separate Focalist handheld robot now guides ultrasound-based needle placement; its longer-term thesis is that remote expertise and precise physical guidance belong in the same procedural workflow.

- **Founded:** 2017
- **Headquarters:** Santa Clara, United States
- **Founders:** Daniel Hawkins (Founder and former CEO of Avail Medsystems)
- **Products:** Avail System, Avail Remote App and Portal, Focalist System (Mendaera)
- **Notable:** Avail reported 50 contracted MedTech organizations in August 2022., Avail completed a SOC 2 Type 2 examination with zero exceptions in 2022., Mendaera acquired substantially all of Avail's assets in March 2024.

## Products & services

- **Avail System** — Mobile operating-room console with remotely controllable HD cameras, two-way audio, imaging inputs and live annotation for procedural collaboration.
- **Avail Remote App and Portal** — Tablet and laptop access for remote observers, plus scheduling and network management tools for clinicians and device professionals.
- **Focalist System (Mendaera)** — FDA-cleared handheld robotic guidance system that pairs with compatible ultrasound probes to guide placement of common interventional devices during diagnostic or therapeutic procedures.

## Achievements

- Avail reported 50 contracted MedTech organizations in August 2022.
- Avail completed a SOC 2 Type 2 examination with zero exceptions in 2022.
- Mendaera acquired substantially all of Avail's assets in March 2024.
- Mendaera's Focalist received FDA 510(k) clearance in July 2025.
- A 2026 prospective single-center feasibility study reported technical success in 60 of 61 Focalist-assisted procedures, with no device-related adverse events.

## Latest updates

- **2026-09** — UAB reported surgeon Kyle Wood's use of Focalist during kidney-stone procedures.
- **2026-08** — Mendaera publicized a peer-reviewed feasibility study reporting 60 successful procedures out of 61.
- **2025-09** — Mendaera announced first Focalist procedures and a limited U.S. urology launch.
- **2025-07** — FDA cleared Mendaera Guidance System under 510(k) K250524.
- **2024-03** — Mendaera acquired Avail's telepresence technology and said it would support existing Avail users.

## Links

- Website: https://www.mendaera.com/
- LinkedIn: https://www.linkedin.com/company/avail-medsystems
- Twitter/X: https://x.com/AvailMedsystems

---

Profile page: https://yespress.io/avail-medsystems-has-moved-to-mendaera
Published by YesPress — https://yespress.io
Last updated: 2026-09-30